The Psychiatric Interview in Clinical Practice (Record no. 17692)

MARC details
000 -LEADER
fixed length control field 01700nam a22002417a 4500
001 - CONTROL NUMBER
control field A. 2916
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240305193413.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 220505b |||||||| |||| 00| 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 072165973X
International Standard Book Number 9780721659732
040 ## - CATALOGING SOURCE
Transcribing agency DLC
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.89 MAC
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Roger A. MacKinnon
9 (RLIN) 36746
245 ## - TITLE STATEMENT
Title The Psychiatric Interview in Clinical Practice
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. London
Name of publisher, distributor, etc. Saunders, 1971 Original from the University of Michigan Digitized
Date of publication, distribution, etc. 27 Aug 2007
300 ## - PHYSICAL DESCRIPTION
Extent 473 pages
520 ## - SUMMARY, ETC.
Summary, etc. One of the major breakthroughs in the treatment of cardiovascular disease has been the introduction of fibrinolytic therapy. Better knowledge of the pathogenesis of acute ischemic syndromes has identified acute thrombosis as the triggering event in most cases. Thrombosis of large and small arteries may have catastrophic consequences as sudden death, myocardial infarction, ischemic stroke, pulmonary embolism and acute limb necrosis. Fibrinolytic therapy is aimed at early restoration of occluded blood vessels thereby improving symptoms and organ recovery, reducing infarct size and subsequently improving quantity and quality of life. However, fibrinolytic drugs have severe, sometimes fatal side-effects. They mainly consist of bleeding, sometimes fatal cerebral bleeding. Therefore, stringent patient selection is mandatory: age, time to treatment, relative and absolute contraindications and comitant medication are of utmost importance for safe and efficacious fibrinolysis.
600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME
General subdivision Medical / Psychiatry / General
9 (RLIN) 26946
General subdivision Medical › Psychiatry › General
9 (RLIN) 26951
700 ## - ADDED ENTRY--PERSONAL NAME
9 (RLIN) 36747
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme ddc
Koha item type BOOKS
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Collection Home library Current library Shelving location Date acquired Total checkouts Full call number Barcode Date last seen Price effective from Koha item type
            MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO   05/05/2022   616.89 MAC A. 2916 05/05/2022 05/05/2022 BOOKS
Catholic University of  Health and Allied Sciences - CUHAS
Directorate of ICT @ 2024